In Vitro Ribosome Assembly Using Physiological Buffer Conditions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro ribosome reconstitution methods are inefficient, particularly for 50S subunits, and face challenges in accurately reflecting in vivo processes due to non-physiological conditions and the need for post-transcriptional modifications, limiting the study of ribosome biogenesis and engineering.
Innovation Solution
A platform and method for preparing sequence-defined biopolymers in vitro using a ribosome-depleted cellular extract, in vitro transcribed ribosomal RNAs, and purified ribosomal proteins, with optimized conditions for ribosome assembly and translation, including the use of ribozymes for efficient rRNA processing and stoichiometric balancing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional reconstitution protocols are used, then ribosome assembly can be achieved, but the efficiency is extremely low (up to 10,000 times less efficient for 50S subunits)
Solution Approach 1:
The patent changes the chemical parameters of the reconstitution buffer, specifically using physiological salt concentrations (100-300 mM KCl, 10-20 mM MgCl2) instead of conventional low salt conditions, and adjusts pH to 7.0-7.5. These parameter changes enable efficient assembly of 50S subunits from in vitro-transcribed rRNA and purified proteins, achieving near-native assembly efficiency without requiring post-transcriptional modifications.
Solution Approach 2:
The patent introduces purified initiation factors (IF1, IF2, IF3) and elongation factors as intermediaries to facilitate the assembly process. These factors act as mediators that promote proper rRNA-protein interactions and guide the formation of functional ribosomal subunits, significantly enhancing assembly efficiency compared to direct reconstitution without factors.
2Ease of manufacture
If in vitro-transcribed rRNA is used without post-transcriptional modifications, then the process is simpler, but reconstitution efficiency drops dramatically
Solution Approach 1:
The patent employs altered buffer parameters including physiological salt concentrations (100-300 mM KCl, 10-20 mM MgCl2), specific pH (7.0-7.5), and the presence of polyamines (spermidine, putrescine) to create conditions where unmodified in vitro-transcribed rRNA can efficiently assemble into functional ribosomes, eliminating the need for complex post-transcriptional modification protocols.
Solution Approach 2:
The patent uses in vitro transcription systems to produce rRNA copies that mimic native rRNA structure and function. By optimizing transcription conditions and using highly processive RNA polymerases, the system generates rRNA molecules that are functional equivalents of native rRNA, enabling efficient ribosome assembly without requiring additional modification steps.
3Productivity
If non-physiological high-temperature incubation is used for 50S assembly, then assembly can proceed, but it precludes coupling with rRNA synthesis
Solution Approach 1:
The patent shifts the temperature parameter from conventional high-temperature incubation (44-50°C) to physiological temperature (37°C), and adjusts salt concentrations to physiological ranges. This enables the assembly process to occur under conditions compatible with simultaneous rRNA synthesis and processing, allowing integration of multiple ribosome biogenesis steps into a single coupled reaction system.
Solution Approach 2:
The patent merges previously separate steps of rRNA synthesis, processing, and ribosome assembly into a single integrated in vitro system. By using physiological conditions that support all these processes simultaneously, the system allows rRNA to be transcribed, processed by RNases, and assembled with proteins in one coupled reaction, mirroring in vivo ribosome biogenesis more accurately.
4Reliability
If purified native ribosomal components are used, then assembly can be achieved, but it does not accurately reflect simultaneous in vivo processes
Solution Approach 1:
The patent performs preliminary preparation of all necessary components (rRNA transcription templates, purified ribosomal proteins, initiation and elongation factors, and buffer components) under conditions that mimic the in vivo environment. This preliminary setup enables the subsequent reaction to accurately reflect simultaneous in vivo processes of rRNA synthesis, processing, and assembly without requiring sequential purification and reconstitution steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances ribosomal activity by three orders of magnitude, overcoming previous inefficiencies and allowing for more accurate and efficient ribosome assembly and translation, enabling the study of ribosome biogenesis and engineering.
Implementation Method 1
assembly with purified total protein of 70S ribosomes (TP70), and translation of a reporter protein such as luciferase or superfolder GFP (sfGFP) as a measure of ribosome activity
Implementation Method 2
single peptide bonds are formed on isolated 50S subunits
Data Source
AI summary
A platform for preparing a sequence defined biopolymer in vitro is disclosed. The platform includes a ribosome-depleted cellular extract ribosomal RNAs prepared by in vitro transcription and purified ribosomal proteins depleted of ribosomal RNAs. A method of synthesizing and assembling ribosomes in vitro for use in the platform is provided, as well as a method for preparing a sequence defined biopolymer in vitro using assembling ribosomes and the platform.